Description

BSE lists new Commercial Paper securities worth Rs. 125 crores issued by ICICI HOME FINANCE COMPANY LIMITED on private placement basis, effective November 6, 2025.

Summary

BSE has listed new Commercial Paper securities issued by ICICI HOME FINANCE COMPANY LIMITED on private placement basis with effect from November 6, 2025. The issuance consists of 2,500 units of Commercial Paper with a face value of Rs. 5,00,000 each, totaling Rs. 125 crores. The securities are rated CARE A1+ and ICRA A1+ and will mature on February 5, 2026.

Key Points

  • Securities Description: Commercial Paper issued on private placement basis
  • Face Value: Rs. 5,00,000 per unit
  • Total Quantity: 2,500 units (Rs. 125 crores)
  • Issue Price: Rs. 4,92,546 per unit
  • Scrip Code: 730506
  • Scrip ID: IHF061125
  • ISIN Number: INE071G14HE0
  • Credit Rating: CARE A1+ and ICRA A1+
  • Market Lot: 1 unit
  • Trading denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Trading mode: Dematerialized form only
  • Issuing and Paying Agent: ICICI Bank Limited

Regulatory Changes

No regulatory changes are introduced through this circular. This is a routine listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE071G14HE0
  • Trading shall be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • The tick size for these securities is 1 paise

Important Dates

  • Date of Allotment: November 6, 2025
  • Listing Date: November 6, 2025
  • Redemption Date: February 5, 2026

Impact Assessment

This is a routine debt market listing with minimal market impact. The listing adds short-term debt instruments to BSE’s debt segment, providing investment options for institutional investors. The high credit ratings (A1+ from both CARE and ICRA) indicate strong creditworthiness. The 91-day maturity commercial paper has no impact on equity markets or broader regulatory framework. Trading members dealing in debt securities should note the specific trading parameters.

Impact Justification

Routine commercial paper listing with no market-wide regulatory implications or equity market impact